Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jenny-Maria Jönsson"'
Autor:
Jenny-Maria Jönsson, Nicolai Skovbjerg Arildsen, Susanne Malander, Anna Måsbäck, Linda Hartman, Mef Nilbert, Ingrid Hedenfalk
Publikováno v:
Translational Oncology, Vol 8, Iss 5, Pp 424-433 (2015)
Background and Aims: Although most ovarian cancers express estrogen (ER), progesterone (PR), and androgen (AR) receptors, they are currently not applied in clinical decision making. We explored the prognostic impact of sex steroid hormone receptor pr
Externí odkaz:
https://doaj.org/article/4c17d2cdcd7b4afba96f4e5b0d7d131f
Autor:
Nicolai Skovbjerg Arildsen, Jenny-Maria Jönsson, Katarina Bartuma, Anna Ebbesson, Sofia Westbom-Fremer, Anna Måsbäck, Susanne Malander, Mef Nilbert, Ingrid A. Hedenfalk
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
ObjectiveOvarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype with distinct clinical features, but may nonetheless be difficult to distinguish morphologically from other subtypes. There is limited knowledge of genetic events
Externí odkaz:
https://doaj.org/article/07791a094ade4600acdf89a8b1810bfb
Autor:
Jenny-Maria Jönsson, Ida Johansson, Mev Dominguez-Valentin, Siker Kimbung, Mats Jönsson, Jesper Hansen Bonde, Päivi Kannisto, Anna Måsbäck, Susanne Malander, Mef Nilbert, Ingrid Hedenfalk
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107643 (2014)
ObjectiveTranscriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian
Externí odkaz:
https://doaj.org/article/85eda4e688ad494cb2cbd74e0846e38d
Autor:
Maria Bååth, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura Martín de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Gabriella Honeth, Ingrid Hedenfalk
Publikováno v:
Genes
Volume 12
Issue 5
Genes, Vol 12, Iss 742, p 742 (2021)
Volume 12
Issue 5
Genes, Vol 12, Iss 742, p 742 (2021)
Overexpression of the receptor tyrosine kinase MET has been linked to poor survival in several cancer types, and MET has been suggested to interact with stem cell networks. In vitro studies have further suggested a possible benefit of a combined trea
Autor:
Jenny-Maria Jönsson, Maria Bååth, Ida Björnheden, Irem Durmaz Sahin, Anna Måsbäck, Ingrid Hedenfalk
Publikováno v:
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 254, p 254 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 254, p 254 (2021)
Serous endometrial cancer (SEC) resembles high-grade serous ovarian cancer (HGSOC) genetically and clinically, with recurrent copy number alterations, TP53 mutations and a poor prognosis. Thus, SEC patients may benefit from targeted treatments used i
Autor:
Nicolai Skovbjerg Arildsen, Ingrid Hedenfalk, Jenny-Maria Jönsson, Mef Nilbert, Anna Måsbäck, Linda Werner Hartman, Susanne Malander
Publikováno v:
Translational Oncology, Vol 8, Iss 5, Pp 424-433 (2015)
Translational Oncology
Translational Oncology; 8(5), pp 424-433 (2015)
Translational Oncology
Translational Oncology; 8(5), pp 424-433 (2015)
Background and Aims: Although most ovarian cancers express estrogen (ER), progesterone (PR), and androgen (AR) receptors, they are currently not applied in clinical decision making. We explored the prognostic impact of sex steroid hormone receptor pr
Autor:
Linda Werner Hartman, Ingrid Hedenfalk, Jenny-Maria Jönsson, Susanne Malander, Mef Nilbert, Anna Måsbäck, Laura Martin de la Fuente, Anna Ebbesson
Publikováno v:
International Journal of Gynecological Pathology
Supplemental Digital Content is available in the text.
The tight junction protein claudin-4 has been reported to be overexpressed in advanced ovarian cancer. We investigated the prognostic significance of claudin-4 overexpression and whether cla
The tight junction protein claudin-4 has been reported to be overexpressed in advanced ovarian cancer. We investigated the prognostic significance of claudin-4 overexpression and whether cla
Autor:
Anna Måsbäck, Päivi Kannisto, Jenny-Maria Jönsson, Siker Kimbung, Ingrid Hedenfalk, Mats Jönsson, Mev Dominguez-Valentin, Ida Johansson, Susanne Malander, Jesper Bonde, Mef Nilbert
Publikováno v:
PLoS ONE; 9(9), no e107643 (2014)
PLoS ONE, Vol 9, Iss 9, p e107643 (2014)
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e107643 (2014)
PLoS ONE
ObjectiveTranscriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cdbcdc011b7593b58efc81b3cb48452
https://lup.lub.lu.se/record/4691427
https://lup.lub.lu.se/record/4691427
Autor:
Ana Carneiro, Zohreh Ketabi, Jenny-Maria Jönsson, Anna Måsbäck, Mef Nilbert, Susanne Malander, Katja Harbst, Göran Jönsson, Mev Dominguez-Valentin, Mats Jönsson, Katarina Bartuma
Publikováno v:
Familial Cancer; 13(4), pp 537-545 (2014)
Familial Cancer
Familial Cancer
Ovarian cancer linked to Lynch syndrome represents a rare subset that typically presents at young age as early-stage tumors with an overrepresentation of endometrioid and clear cell histologies. We investigated the molecular profiles of Lynch syndrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8119b069f14535d061fc00c4942fa4d6
https://lup.lub.lu.se/record/4453962
https://lup.lub.lu.se/record/4453962
Autor:
Jenny-Maria Jönsson, Anna Ebbesson, Anna Måsbäck, Susanne Malander, Nicolai Skovbjerg Arildsen, Mef Nilbert, Ingrid Hedenfalk, Sofia Westbom-Fremer
Publikováno v:
Clinical Cancer Research. 22:B12-B12
Objective: Ovarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype. Despite relatively clear clinical features, OCCCs can be difficult to distinguish morphologically from other epithelial ovarian cancers. OCCC gene expression s